AHSAX Mutual Fund

NAV$26.92

Fund Essentials - as of Jan 30, 2026

Net Assets
$50M
Expense Ratio
1.17%
Dividend Yield (Current)
-
Holdings
55
Inception Date
May 1, 2002
Fund Family
Alger
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+18.85%
1 Year+35.84%
3 Year+6.75%
5 Year+3.12%
10 Year+14.99%

Asset Allocation

Stocks: 99.46%
Cash: 0.54%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
FBRXForte Biosciences Inc5.49%
TEVA:ILTeva Pharmaceutical Industries Limited (Adr)4.74%
LLYEli Lilly & Co4.59%
CAHCardinal Health4.54%
-Toronto-Dominion Bank 7.25% 07/31/2084 7.25 2084-07-314.31%
Top 10 Concentration: 41.83%Report Date: Jan 30, 2026
Download all 55 holdings for AHSAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$3.75
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

AHSAX Mutual Fund Overview

AHSAX Mutual Fund (Alger Health Sciences Fund Class A) is managed by Alger with $49.8M in net assets. AHSAX expense ratio is 1.17%, holding 55 positions across sectors including Health Care, Unknown, Other. Inception date: 2002-05-01.

AHSAX performance shows a YTD return of 18.85%. The 1-year return is 35.84% and the 5-year return is 3.12%.

AHSAX top holdings include Forte Biosciences Inc (5.5%), Teva Pharmaceutical Industries Limited (Adr) (4.7%), Eli Lilly & Co (4.6%), Cardinal Health (4.5%), Toronto-Dominion Bank 7.25% 07/31/2084 7.25 2084-07-31 (4.3%). View all AHSAX holdings, sector breakdown, or dividend history.

AHSAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. AHSAX alternatives are available via the screener, along with tax-loss harvesting opportunities.